Spine. 2026;51(15):1101–1107
Objective
To determine whether ketorolac administered within 48 hours of multilevel posterior cervical decompression and fusion increases the risk of pseudoarthrosis.
Methods
Retrospective TriNetX database study covering 2002–2024. Propensity matching produced two cohorts of 1,376 patients treated with ketorolac or acetaminophen alone.
Main results
Pseudoarthrosis rates were similar at one year (6.3% in both groups) and four years (8.1% versus 8.4%). There were also no significant differences in reoperation, hardware complications, infection, bleeding or thromboembolic events. Ketorolac was associated with a modest reduction in later opioid prescriptions (RR 0.909; 95% CI 0.834–0.980).
Interpretation
Short-term postoperative ketorolac was not associated with impaired fusion in this matched cohort. This supports its cautious inclusion in multimodal analgesia after posterior cervical fusion.
Limitations
Retrospective database study dependent on diagnostic and medication coding. Dose, duration, adherence, imaging confirmation of fusion and over-the-counter NSAID exposure could not be fully assessed.
Clinical takeaway
A limited postoperative ketorolac regimen does not appear to produce a clinically meaningful increase in pseudoarthrosis following multilevel posterior cervical fusion.



















You must be logged in to post a comment.